375 related articles for article (PubMed ID: 23187837)
1. Multimodality imaging of pancreatic cancer-computed tomography, magnetic resonance imaging, and positron emission tomography.
Raman SP; Horton KM; Fishman EK
Cancer J; 2012; 18(6):511-22. PubMed ID: 23187837
[TBL] [Abstract][Full Text] [Related]
2. Imaging of pancreatic neoplasms.
Balachandran A; Bhosale PR; Charnsangavej C; Tamm EP
Surg Oncol Clin N Am; 2014 Oct; 23(4):751-88. PubMed ID: 25246049
[TBL] [Abstract][Full Text] [Related]
3. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
[TBL] [Abstract][Full Text] [Related]
4. The value of positron emission tomography/computed tomography for evaluating metastatic disease in patients with pancreatic cancer.
Kim MJ; Lee KH; Lee KT; Lee JK; Ku BH; Oh CR; Heo JS; Choi SH; Choi DW
Pancreas; 2012 Aug; 41(6):897-903. PubMed ID: 22699202
[TBL] [Abstract][Full Text] [Related]
5. Imaging for pancreatic ductal adenocarcinoma.
Horvat N; Ryan DE; LaGratta MD; Shah PM; Do RK
Chin Clin Oncol; 2017 Dec; 6(6):62. PubMed ID: 29307202
[TBL] [Abstract][Full Text] [Related]
6. Cross-sectional imaging and the role of positron emission tomography in pancreatic cancer evaluation.
Raman SP; Chen Y; Fishman EK
Semin Oncol; 2015 Feb; 42(1):40-58. PubMed ID: 25726051
[TBL] [Abstract][Full Text] [Related]
7. MRI of adenocarcinoma of the pancreas.
Miller FH; Rini NJ; Keppke AL
AJR Am J Roentgenol; 2006 Oct; 187(4):W365-74. PubMed ID: 16985107
[TBL] [Abstract][Full Text] [Related]
8. [Radiological evaluation of pancreatic ductal adenocarcinoma].
Akai H; Otomo K
Gan To Kagaku Ryoho; 2012 Mar; 39(3):342-6. PubMed ID: 22421758
[TBL] [Abstract][Full Text] [Related]
9. Pictorial essay: multimodality imaging of metastases from pancreatic ductal adenocarcinoma.
Ozkan E; Balachandran A; Bhosale PR; Tamm EP; Marcal LP; Szklaruk J
Clin Imaging; 2010; 34(4):277-87. PubMed ID: 20630340
[TBL] [Abstract][Full Text] [Related]
10. Comparison of F-18-FDG PET/CT findings between pancreatic solid pseudopapillary tumor and pancreatic ductal adenocarcinoma.
Kim YI; Kim SK; Paeng JC; Lee HY
Eur J Radiol; 2014 Jan; 83(1):231-5. PubMed ID: 24290142
[TBL] [Abstract][Full Text] [Related]
11. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
[TBL] [Abstract][Full Text] [Related]
12. 18-fluorodeoxyglucose positron emission tomography enhances computed tomography diagnosis of malignant intraductal papillary mucinous neoplasms of the pancreas.
Sperti C; Bissoli S; Pasquali C; Frison L; Liessi G; Chierichetti F; Pedrazzoli S
Ann Surg; 2007 Dec; 246(6):932-7; discussion 937-9. PubMed ID: 18043094
[TBL] [Abstract][Full Text] [Related]
13. Pancreatic carcinoma: Key-points from diagnosis to treatment.
Frampas E; David A; Regenet N; Touchefeu Y; Meyer J; Morla O
Diagn Interv Imaging; 2016 Dec; 97(12):1207-1223. PubMed ID: 27567314
[TBL] [Abstract][Full Text] [Related]
14. [Ductal adenocarcinoma and unusual differential diagnosis].
Haage P; Schwartz CA; Scharwächter C
Radiologe; 2016 Apr; 56(4):325-37. PubMed ID: 27000276
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic imaging for pancreatic cancer: computed tomography, magnetic resonance imaging, and positron emission tomography.
Saisho H; Yamaguchi T
Pancreas; 2004 Apr; 28(3):273-8. PubMed ID: 15084970
[TBL] [Abstract][Full Text] [Related]
16. Intraductal papillary-mucinous tumor of the pancreas: the clinical research continues.
Pezzilli R
JOP; 2004 Jan; 5(1):53-5. PubMed ID: 14730125
[No Abstract] [Full Text] [Related]
17. Staging of pancreatic adenocarcinoma by imaging studies.
Wong JC; Lu DS
Clin Gastroenterol Hepatol; 2008 Dec; 6(12):1301-8. PubMed ID: 18948228
[TBL] [Abstract][Full Text] [Related]
18. The clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the differential diagnosis, staging, and response evaluation after concurrent chemoradiotherapy for pancreatic cancer.
Bang S; Chung HW; Park SW; Chung JB; Yun M; Lee JD; Song SY
J Clin Gastroenterol; 2006; 40(10):923-9. PubMed ID: 17063113
[TBL] [Abstract][Full Text] [Related]
19. Role of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in diagnosis and management of pancreatic cancer; comparison with multidetector row computed tomography, magnetic resonance imaging and endoscopic ultrasonography.
Ergul N; Gundogan C; Tozlu M; Toprak H; Kadıoglu H; Aydin M; Cermik TF
Rev Esp Med Nucl Imagen Mol; 2014; 33(3):159-64. PubMed ID: 24140024
[TBL] [Abstract][Full Text] [Related]
20. Imaging of pancreatic adenocarcinoma: update on staging/resectability.
Tamm EP; Balachandran A; Bhosale PR; Katz MH; Fleming JB; Lee JH; Varadhachary GR
Radiol Clin North Am; 2012 May; 50(3):407-28. PubMed ID: 22560689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
